Abstract

Objective: To compare the effectiveness of 70‐mg and 200‐mg doses of IV erythromycin in improving gastric emptying in critically ill patients. Design: Gastric emptying was measured on consecutive days; day 1 (pretreatment), day 2 (posttreatment) after an IV infusion of either 70 or 200 mg erythromycin or saline placebo (0.9%), in a randomized double‐blind fashion. Setting: Mixed medical/surgical intensive care unit, tertiary referral. Patients and Participants: Thirty‐five randomly selected, mechanically ventilated, enterally fed critically ill patients (median APACHE II score 19 on admission). Interventions: On day 2, either 70 or 200 mg erythromycin or saline was administered IV over 20 min. Measurements and Results: Gastric emptying was measured using the [13C]octanoic acid breath test. The gastric emptying coefficient (GEC) and half‐emptying time (t½) were calculated from the area under the 13CO2‐recovery curve. Pretreatment gastric emptying measurements were similar in all 3 patient groups. Treatment with both doses of erythromycin significantly reduced the gastric t½: 70 mg, 98 min (IQR 88–112); 200 mg, 86 min (75–104); vs placebo, 122 min (102–190) (p < .05). The GEC was higher with both doses of erythromycin: 70 mg, 3.8 (3.3–4.0); 200 mg, 4.0 (3.6–4.2); vs placebo, 2.9 (2.5–3.7) (p < .05). There was no difference in gastric emptying posttreatment between the 2 doses of erythromycin. The effect of erythromycin was greatest in patients with delayed gastric emptying. Conclusions: Treatment with 70 and 200 mg IV erythromycin is equally effective in accelerating gastric emptying in the critically ill.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.